Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge Model

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01397227
Recruitment Status : Completed
First Posted : July 19, 2011
Last Update Posted : September 7, 2012
Sponsor:
Collaborators:
The PATH Malaria Vaccine Initiative (MVI)
Seattle Children’s Research Institute (SCRI)
Information provided by (Responsible Party):
Crucell Holland BV

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2012
Actual Study Completion Date : May 2012
Certification/Extension First Submitted : September 3, 2012